Valuation: Caplin Point Laboratories Limited

Market Cap 187B 1.94B 1.71B 1.58B 1.46B 2.74B 2.77B 18.78B 7.37B 91.8B 7.28B 7.13B 318B P/E 2026
17.9x
P/E 2027 * 26.3x
Enterprise Value 187B 1.94B 1.71B 1.58B 1.46B 2.74B 2.77B 18.78B 7.37B 91.8B 7.28B 7.13B 318B EV / Sales 2026
5.23x
EV / Sales 2027 * 7.53x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.16%
1 day-0.90%
1 week-5.71%
Current month-6.08%
1 month-1.70%
3 months+43.56%
6 months+43.17%
Current year+33.86%
1 week 2,455
Extreme 2455
2,680
1 month 2,455
Extreme 2455
2,700
Current year 1,502.45
Extreme 1502.45
2,700
1 year 1,502.45
Extreme 1502.45
2,700
3 years 840.05
Extreme 840.05
2,700
5 years 575
Extreme 575
2,700
10 years 180
Extreme 180
2,700
Manager TitleAgeSince
Chief Executive Officer 71 2015-03-27
Director of Finance/CFO - 2016-02-18
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 2010-01-26
Director/Board Member - 2025-11-04
Director/Board Member 71 2015-03-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%-5.71%+20.99%+187.21% 1.95B
-0.66%+0.44%+14.25%+77.26% 48.36B
+2.20%+1.41%+57.98%+112.68% 35.8B
+1.26%-0.57%-7.95%+33.74% 11.83B
-0.46%-3.06%+13.55%+78.32% 11.48B
+0.19%-2.61%+34.45%+135.59% 9.01B
+1.52%+0.39%+49.34%-7.78% 6.99B
-0.17%-2.92%+11.72%+32.23% 6.7B
-0.59%-1.95%+2.18%+179.57% 6.42B
-7.92%-13.61%-33.87%-3.07% 5.3B
Average -0.55%-2.79%+16.26%+82.57% 14.38B
Weighted average by Cap. +0.14%-0.72%+23.88%+83.10%

Financials

2026 2027 *
Net sales 21.28B 220M 194M 180M 165M 311M 315M 2.13B 837M 10.43B 827M 809M 36.12B 24.88B 258M 227M 210M 193M 363M 368M 2.49B 979M 12.19B 967M 946M 42.23B
Net income 6.16B 63.82M 56.15M 52.04M 47.92M 89.96M 91.21M 618M 242M 3.02B 239M 234M 10.46B 7.13B 73.82M 64.95M 60.19M 55.42M 104M 106M 714M 280M 3.49B 277M 271M 12.1B
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
26-07-24 ₹2,464.65 -0.90% 8,465
26-07-23 ₹2,487.15 +0.25% 9,678
26-07-22 ₹2,480.95 -4.84% 9,799
26-07-21 ₹2,607.05 -1.54% 3,049
26-07-20 ₹2,647.75 +1.29% 2,358
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,464.65INR
Average target price
2,505.00INR
Spread / Average Target
+1.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAPLIPOINT Stock